Clinical trial
Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery
NCT00335244 · Asklepion Pharmaceuticals, LLC, Industry · Completed
Key facts
| NCT number | NCT00335244 |
|---|---|
| Title | Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery |
| Official title | A Phase III Single-Blind, Randomized, Placebo Controlled, Clinical Trial to Determine the Safety and Efficacy of Intravenous L-Citrulline Versus Placebo in Children Undergoing Cardiopulmonary Bypass |
| Lead sponsor | Asklepion Pharmaceuticals, LLC, Industry |
| Collaborators | Vanderbilt University |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Defects, Congenital, Hypertension, Pulmonary |
| Intervention type | Drug |
| Interventions | L-citrulline, Placebo of intravenous L-citrulline |
| Enrollment | 77 |
| Start date | May 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Jun 9, 2006 |
| Last update posted | Feb 2, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: